STOCK TITAN

The Joint Corp. to reacquire Texas rights for $8M cash

The Sellers received approximately $2.3 million in Texas franchisee royalties during the trailing twelve months ended August 31, 2026.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

The Joint Corp. entered an Asset Purchase Agreement with Texas entities referred to collectively as the Sellers. The agreement provides that it will reacquire certain regional development rights in Texas and mutually terminate the related regional developer agreements, effective at 12:01 a.m. on October 1, 2026. David Glover and Anne Glover are limited partners of The Joint Franchises Texas, Ltd. The Texas region included 141 franchised clinics as of October 1, 2026; following the transaction, the Sellers will continue franchising eight clinics through their affiliates.

The Joint Corp. will pay $8.0 million in cash upon execution. It may pay up to $2.0 million in additional consideration if certain gross sales metrics are met or exceeded during the two annual periods beginning September 1, 2026; the additional payments are split evenly between the two years.

Filing Explained

The terminated Texas regional agreements included renewal rights for multiple successive 10-year terms, so the unwind also ends those renewal provisions.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Cash purchase price $8.0 million Due upon execution of the agreement
Additional consideration Up to $2.0 million Conditional on certain gross sales metrics during the two annual periods beginning September 1, 2026
Franchised clinics in Texas region 141 clinics As of October 1, 2026
Clinics remaining with Sellers Eight clinics The Sellers will continue franchising these clinics through their affiliates following the transaction
Royalties paid to Sellers Approximately $2.3 million Trailing twelve months ended August 31, 2026
Gross sales measurement periods Two annual periods Beginning September 1, 2026
Asset Purchase Agreement technical
"entered into an Asset Purchase Agreement"
An asset purchase agreement is a legal contract in which a buyer agrees to buy specific assets and contracts of a business rather than buying the company’s stock or ownership. It matters to investors because it determines exactly what is being bought and what liabilities stay behind — like buying the furniture and equipment from a store but not the building or past debts — which affects the deal’s value, taxes and future risk exposure.
regional development rights technical
"reacquire certain regional development rights in the Texas region"
regional developer agreements technical
"mutually terminate the related regional developer agreements"
gross sales metrics financial
"if certain gross sales metrics are met or exceeded"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much is JYNT paying to reacquire Texas development rights?

The Joint Corp. will pay $8.0 million in cash upon execution, with up to $2.0 million in additional consideration if certain gross sales metrics are met or exceeded during the two annual periods beginning September 1, 2026. The additional payments are split evenly between the two years.

What renewal terms did JYNT's Texas regional developer agreements include?

The Texas regional developer agreements included renewal rights for multiple successive 10-year terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
0001612630FALSE00016126302026-10-012026-10-01

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 1, 2026

The Joint Corp.
(Exact Name of Registrant as Specified in Charter)

Delaware001-36724 90-0544160
(State or other jurisdiction(Commission File Number)(IRS Employer
of incorporation)Identification No.)
16767 N. Perimeter Drive, Suite 110
Scottsdale, Arizona 85260
(Address of principal executive offices) (Zip Code)

(480) 245-5960
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 Par Value Per ShareJYNT
The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐




If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry Into a Material Definitive Agreement.

On October 1, 2026, we entered into an Asset Purchase Agreement (the “APA”) with The Joint Franchises San Antonio, LLC, a Texas limited liability company, The Joint Franchises DFW, LLC, a Texas limited liability company, The Joint Franchises Houston, LLC, a Texas limited liability company, The Joint Franchises Austin, LLC, a Texas limited liability company, and The Joint Franchises Texas, Ltd., a Texas limited partnership, of which David Glover and Anne Glover, residents of Texas, are the limited partners (referred to collectively as the “Sellers” and individually as a “Seller”), pursuant to which effective at 12:01 a.m. on October 1, 2026, we will reacquire from the Sellers certain regional development rights in the Texas region, and mutually terminate the related regional developer agreements with the Sellers in the Texas region (collectively, the “Texas RDAs”). As of October 1, 2026, the Texas region includes 141 franchised clinics and following the transaction, the Sellers will continue to franchise eight clinics in Texas through their affiliates.

The Texas RDAs are among the Company’s earliest regional developer agreements and included certain negotiated terms such as renewal rights for multiple successive 10-year terms. Pursuant to the Texas RDAs, the Sellers received approximately $2.3 million in royalties paid by franchisees in the Texas region during the trailing twelve months ended August 31, 2026. Based on the foregoing, the aggregate purchase price we will pay to Seller is $8.0 million in cash due upon execution of the agreement, and if certain gross sales metrics are met or exceeded under these Texas RDAs during the two annual periods beginning September 1, 2026, up to $2.0 million in additional consideration payments, split evenly between the two years.

The APA also contains other provisions, covenants, representations, and warranties that are typical in transactions of this size, type, and complexity.

The description of the APA does not purport to be complete, and such description is qualified in its entirety by reference to the complete terms of the APA, which will be filed as an exhibit to our Annual Report on Form 10-K.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE JOINT CORP.
Date:October 1, 2026By:/s/ Sanjiv Razdan
Sanjiv Razdan
President and Chief Executive Officer

Filing Exhibits & Attachments

3 documents

Keep reading